CXCR4, an emerging key therapeutic target. Conigen is developing an innovative #CXCR4 platform for conducting in vivo animal #immunization and in vitro #bioassays. This platform supports research in areas such as #receptorligandinteractions, #drugscreening, and #mechanisticstudies. bit.ly/3ONMzlL
0
0
0
0